|
Functional class | Probe set ID | F.C. | Regulation | Gene symbol | Gene title | Accession number |
|
Immune response | 206486_at | 1.5 | Up | LAG3 | Lymphocyte-activation gene 3 | NM_002286 |
204352_at | 1.6 | Up | TRAF5 | TNF receptor-associated factor 5 | NM_004619 |
205821_at | 1.7 | Up | KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | NM_007360 |
203717_at | 2.4 | Up | DPP4 | Dipeptidyl peptidase 4 | NM_001935 |
203939_at | 3.8 | Up | NT5E | 5′-nucleotidase, ecto (CD73) | NM_002526 |
204502_at | 2.0 | Up | SAMHD1 | SAM domain and HD domain 1 | NM_015474 |
|
Inflammation | 206332_s_at | 3.1 | Up | IFI16 | Interferon, gamma-inducible protein 16 | NM_005531 |
217738_at | 2.0 | Up | NAMPT | Nicotinamide phosphoribosyltransferase | NM_005746 |
203176_s_at | 2.2 | Up | TFAM | Transcription factor A, mitochondrial | NM_003201 |
205870_at | 2.2 | Up | BDKRB2 | Bradykinin receptor B2 | NM_000623 |
204655_at | 2.2 | Up | CCL5 | Chemokine (C-C motif) ligand 5 | NM_002985 |
209392_at | 2.3 | Up | ENPP2 | Ectonucleotidepyrophosphatase | L35594 |
202859_x_at | 2.3 | Up | IL8 | Interleukin 8 | NM_000584 |
211272_s_at | 2.4 | Down | DGKA | Diacylglycerol kinase, alpha 80 kDa | AF064771 |
207177_at | 2.5 | Up | PTGFR | Prostaglandin F receptor | NM_000959 |
208782_at | 2.9 | Up | FSTL1 | Follistatin-like 1 | BC000055 |
204563_at | 7.3 | Up | SELL | Selectin L | NM_000655 |
206211_at | 4.3 | Up | SELE | Selectin E | NM_000450 |
217800_s_at | 1.9 | Up | NDFIP1 | Nedd4 family interacting protein 1 | NM_030571 |
214475_x_at | 2.8 | Down | CAPN3 | Calpain 3, (p94) | AF127764 |
201859_at | 3.1 | Up | SRGN | Serglycin | NM_002727 |
201110_s_at | 5.2 | Up | THBS1 | Thrombospondin 1 | NM_003246 |
|
Apoptosis | 202558_s_at | 1.5 | Up | STCH | Stress 70 protein chaperone | NM_006948 |
217786_at | 1.5 | Down | PRMT5 | Protein arginine methyltransferase 5 | NM_006109 |
204781_s_at | 1.5 | Up | FAS | TNF receptor superfamily, member 6 | NM_000043 |
202693_s_at | 1.7 | Up | STK17A | Serine/threonine kinase 17a | NM_004760 |
201912_s_at | 2.6 | Up | GSPT1 | G1 to S phase transition 1 | NM_002094 |
202887_s_at | 2.6 | Down | DDIT4 | DNA-damage-inducible transcript 4 | NM_019058 |
202687_s_at | 2.9 | Up | TNFSF10 | Tumor necrosis factor (ligand) superfamily, member 10 | NM_003810 |
202411_at | 3.1 | Up | IFI27 | Interferon, alpha-inducible protein 27 | NM_005532 |
202391_at | 3.1 | Up | BASP1 | Brain abundant, membrane-attached signal protein 1 | NM_006317 |
|
Cell proliferation | 208676_s_at | 1.5 | Up | PA2G4 | Proliferation-associated 2G4, 38 kDa | U87954 |
205937_at | 1.5 | Up | CGREF1 | Cell growth regulator with EF-hand domain 1 | NM_006569 |
1773_at | 1.5 | Down | FNTB | Farnesyltransferase, CAAX box, beta | L00635 |
202886_s_at | 2.2 | Up | PPP2R1B | Protein phosphatase 2, regulatory subunit A, beta isoform | M65254 |
202167_s_at | 1.9 | Down | MMS19 | MMS19 nucleotide excision repair homolog | NM_022362 |
203108_at | 2.1 | Up | GPRC5A | G protein-coupled receptor, family C, group 5, member A | NM_003979 |
202454_s_at | 2.7 | Down | ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 | NM_001982 |
|
| 204798_at | 1.6 | Up | MYB | v-myb myeloblastosis viral oncogene homolog | NM_005375 |
| 218717_s_at | 1.7 | Up | LEPREL1 | Leprecan-like 1 | NM_018192 |
| 209765_at | 1.8 | Up | ADAM19 | ADAM metallopeptidase domain 19 | AF311317 |
| 202381_at | 1.8 | Up | ADAM9 | ADAM metallopeptidase domain 9 | NM_003816 |
| 203044_at | 2.1 | Up | CHSY1 | Chondroitin sulfate synthase 1 | NM_014918 |
Extracellular matrix | 205479_s_at | 2.1 | Up | PLAU | Plasminogen activator, urokinase | NM_002658 |
210845_s_at | 2.1 | Up | PLAUR | Plasminogen activator, urokinase receptor | U08839 |
201995_at | 2.2 | Up | EXT1 | Exostoses (multiple) 1 | NM_000127 |
205828_at | 3.4 | Up | MMP3 | Matrix metallopeptidase 3 (stromelysin 1) | NM_002422 |
203936_s_at | 2.2 | Up | MMP9 | Matrix metallopeptidase 9 | NM_004994 |
202620_s_at | 2.4 | Up | PLOD2 | Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | NM_000935 |
207316_at | 2.8 | Up | HAS1 | hyaluronan synthase 1 | NM_001523 |
203343_at | 3.2 | Up | UGDH | UDP-glucose dehydrogenase | NM_003359 |
204620_s_at | 4.0 | Up | VCAN | Versican | NM_004385 |
202766_s_at | 5.6 | Up | FBN1 | Fibrillin 1 | NM_000138 |
202404_s_at | 4.1 | Up | COL1A2 | Collagen, type I, alpha 2 | NM_000089 |
201852_x_at | 2.9 | Up | COL3A1 | Collagen, type III, alpha 1 | NM_000090 |
211980_at | 2.4 | Up | COL4A1 | Collagen, type IV, alpha 1 | NM_001845 |
221730_at | 2.7 | Up | COL5A2 | Collagen, type V, alpha 2 | NM_000393 |
207134_x_at | 2.2 | Up | TPSB2 | Tryptase beta 2 | NM_024164 |
210084_x_at | 2.1 | Up | TPSAB1 | Tryptase alpha/beta 1 | AF206665 |
214533_at | 3.5 | Up | CMA1 | Chymase 1, mast cell | NM_001836 |
| 205624_at | 2.1 | Up | CPA3 | Carboxypeptidase A3 (mast cell) | NM_001870 |
| 206871_at | 3.3 | Up | ELA2 | Elastase 2, neutrophil | NM_001972 |
| 205653_at | 5.0 | Up | CTSG | Cathepsin G | NM_001911 |
| 202376_at | 1.7 | Down | SERPINA3 | Serpin peptidase inhibitor, clade A, member 3 | NM_001085 |
| 201147_s_at | 1.8 | Down | TIMP3 | TIMP metallopeptidase inhibitor 3 | NM_000362 |
| 206243_at | 2.8 | Down | TIMP4 | TIMP metallopeptidase inhibitor 4 | NM_003256 |
|
Dermal-epidermal junction | 216971_s_at | 1.5 | Down | PLEC1 | Plectin 1, intermediate filament binding protein | Z54367 |
214292_at | 1.5 | Down | ITGB4 | Integrin, beta 4 | AA808063 |
210150_s_at | 1.5 | Down | LAMA5 | Laminin, alpha 5 | BC003355 |
|
Metabolism
| 207786_at | 1.9 | Down | CYP2R1 | Cytochrome P450, family 2, subfamily R, polypeptide 1 | NM_024514 |
211019_s_at | 2.1 | Down | LSS | 2,3-oxidosqualene-lanosterol cyclase | D63807 |
205676_at | 2.5 | Up | CYP27B1 | Cytochrome P450, family 27, subfamily B, polypeptide 1 | NM_000785 |
|